Issue: February, 2021 - JAMA Pediatrics

$20.00

JAMA Pediatrics is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of pediatrics.
Impact factor: 13.946 (2019)
Publisher: American Medical Association (United States)
History: 1911–present
Editor: Dimitri A. Christakis
Discipline: Pediatrics
LCCN: 95642320

Additional information

Volume

175

Issue

2

Articles:

1. Clarifying the Sweeping Consequences of COVID-19 in Pregnant Women, Newborns, and
Children with Existing Cohorts
2. K-12 Virtual Schooling, COVID-19, and Student Success
3. Operational Considerations on the American Academy of Pediatrics Guidance for K-12
School Re-entry
4. COVID-19 and Human Trafficking—the Amplified Impact on Vulnerable Populations
5. Should We Mandate a COVID-19 Vaccine for Children?
6. It’s Time to Put Children and Young People First During the Global COVID-19 Pandemic
7. Balancing Risks in the Time of COVID-19
8. Ampicillin and Gentamicin in Infants With Suspected Sepsis Long Live Amp and Gent—But
for How Long?
9. Cardiovascular Disease in Former Pediatric Recipients of Growth Hormone Another Look at
Growth Hormone Safety
10. Autism Spectrum Disorder and the Risk of Substance Use Disorder A Call for Targeted
Screening and Prevention in Adolescents
11. Effect of a Home-Visiting Intervention to Reduce Early Childhood Obesity Among Native
American Children: A Randomized Clinical Trial
12. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With
Adults A Systematic Review and Meta-analysis
13. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome
Coronavirus 2 Infection at a Large Medical Center in New York City
14. Antibiotic Susceptibility of Escherichia coli Among Infants Admitted to Neonatal Intensive
Care Units Across the US From 2009 to 2017
15. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome
Coronavirus 2 Across the United States
16. Trends in Use and Perceptions of Nicotine Vaping Among US Youth From 2017 to 2020
17. Association of Childhood Growth Hormone Treatment With Long-term Cardiovascular
Morbidity
18. Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic
Agents in Patients With Autism
19. Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder
20. Frequency of Children vs Adults Carrying Severe Acute Respiratory Syndrome Coronavirus
2 Asymptomatically
21. Polysubstance Involvement in Opioid Overdose Deaths in Adolescents and Young Adults,
1999-2018
22. Characteristics of Youths Treated With Psychotropic Polypharmacy in the United States,
1999 to 2015
23. Prevalence of SARS-CoV-2 Infection in Children Without Symptoms of Coronavirus
Disease 2019
24. Early Formula Supplementation Trends by Race/Ethnicity Among US Children Born From
2009 to 2015
25. Validating the Importance of Positive Childhood Experiences on Adult Mental Health
26. Validating the Importance of Positive Childhood Experiences on Adult Mental
Health—Reply
27. Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric
Atopic Dermatitis

28. Comparing the Roles of Omalizumab and UV Therapy in Treating Severe Pediatric Atopic
Dermatitis—Reply
29. Apgar Score—It Is Time to Avoid Pain
30. Apgar Score—It Is Time to Avoid Pain—Reply
31. High-Flow Nasal Cannula as Rescue Therapy in Bronchiolitis
32. High-Flow Nasal Cannula as Rescue Therapy in Bronchiolitis—Reply
33. Proton Pump Inhibitors and Fractures During Growth
34. Proton Pump Inhibitors and Fractures During Growth—Reply
35. Coronavirus Disease 2019 and Effects of School Closure for Children and Their Families
36. Coronavirus Disease 2019 and Effects of School Closure for Children and Their Families
37. Coronavirus Disease 2019 and Effects of School Closure for Children and Their
Families—Reply